129 related articles for article (PubMed ID: 3949887)
1. Dissociation of cellular transformation from platelet-derived growth factor independence.
Scher CD; Engle LJ; Eberenz WM; Ganguly K; Wharton W
J Cell Physiol; 1986 Mar; 126(3):333-40. PubMed ID: 3949887
[TBL] [Abstract][Full Text] [Related]
2. Modulation of platelet-derived growth factor receptor function in BP3T3, a chemically transformed BALB/c-3T3 cell line.
Grundy P; Bishayee S; Disa S; Scher CD
Cancer Res; 1989 Jul; 49(13):3581-6. PubMed ID: 2543499
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the platelet-derived growth factor induced replicative response.
Scher CD; Whipple AP; Singh JP; Pledger WJ
J Cell Physiol; 1985 Apr; 123(1):10-6. PubMed ID: 3972907
[TBL] [Abstract][Full Text] [Related]
4. Conditional responsiveness of a chemically transformed cell line to growth factor stimulated DNA synthesis.
Whipple AP; Furlanetto RW; Scher CD
J Cell Physiol; 1987 Feb; 130(2):182-90. PubMed ID: 3818800
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Balb/c-3T3 cell cycle-effects of growth factors.
Stiles CD; Pledger WJ; Tucker RW; Martin RG; Scher CD
J Supramol Struct; 1980; 13(4):489-99. PubMed ID: 6453256
[TBL] [Abstract][Full Text] [Related]
6. Expression of platelet-derived growth factor-independent phenotypes in BALB/c 3T3 cell variant with high susceptibility to chemically or physically induced neoplastic cell transformation: dissociation from activation of protein kinase C.
Tatsuka M; Owada MK; Mitsui H
Cancer Res; 1992 Aug; 52(15):4232-41. PubMed ID: 1638537
[TBL] [Abstract][Full Text] [Related]
7. Control of the Balb/c-3T3 cell cycle by nutrients and serum factors: analysis using platelet-derived growth factor and platelet-poor plasma.
Stiles CD; Isberg RR; Pledger WJ; Antoniades HN; Scher CD
J Cell Physiol; 1979 Jun; 99(3):395-405. PubMed ID: 222785
[TBL] [Abstract][Full Text] [Related]
8. Identification of a BALB/c-3T3 cell protein modulated by platelet-derived growth factor.
Scher CD; Dick RL; Whipple AP; Locatell KL
Mol Cell Biol; 1983 Jan; 3(1):70-81. PubMed ID: 6186905
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
11. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
Vennström B; Bravo R
Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775
[TBL] [Abstract][Full Text] [Related]
12. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
[TBL] [Abstract][Full Text] [Related]
13. Identification of a PDGF-like mitoattractant produced by NIH/3T3 cells after transformation with SV40.
Bleiberg I; Harvey AK; Smale G; Grotendorst GR
J Cell Physiol; 1985 May; 123(2):161-6. PubMed ID: 2984217
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor stimulation of [3H]-glucosamine incorporation in density-arrested BALB/c-3T3 cells.
Harrington MA; Wharton W; Pledger WJ
J Cell Physiol; 1987 Jan; 130(1):93-102. PubMed ID: 3805132
[TBL] [Abstract][Full Text] [Related]
15. PDGF-D is a potent transforming and angiogenic growth factor.
Li H; Fredriksson L; Li X; Eriksson U
Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of BALB/c-3T3 cells in late G1: commitment to DNA synthesis controlled by somatomedin C.
Wharton W; Van Wyk JJ; Pledger WJ
J Cell Physiol; 1981 Apr; 107(1):31-9. PubMed ID: 7194350
[TBL] [Abstract][Full Text] [Related]
17. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
Riese DJ; DiMaio D
Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional control of protein synthesis in Balb/c-3T3 cells by platelet-derived growth factor and platelet-poor plasma.
Cochran BH; Lillquist JS; Stiles CD
J Cell Physiol; 1981 Dec; 109(3):429-38. PubMed ID: 6798044
[TBL] [Abstract][Full Text] [Related]
19. Association of increased platelet-derived growth factor secretion and retroviral expression in transformed mouse and human cells.
Fraizer GC; Bowen-Pope DF; Seifert RA; Vogel AM
Cancer Res; 1988 Sep; 48(17):4874-80. PubMed ID: 2842041
[TBL] [Abstract][Full Text] [Related]
20. Growth arrest states of RNA virus- and chemically transformed mouse cells.
Riddle VG; Lehtomaki DM
Cancer Res; 1981 May; 41(5):1778-83. PubMed ID: 6260351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
